Olanzapine for delirium in parkinsonism: therapeutic benefits in lieu of adverse consequences

Neurol India. 2004 Jun;52(2):274-5.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / therapeutic use*
  • Benzodiazepines / adverse effects
  • Benzodiazepines / therapeutic use*
  • Delirium / drug therapy*
  • Delirium / etiology*
  • Female
  • Humans
  • Olanzapine
  • Parkinsonian Disorders / psychology*

Substances

  • Antipsychotic Agents
  • Benzodiazepines
  • Olanzapine